Skip to main content
MedPathMedPath Home
Clinical Trials/RBR-74rr6s
RBR-74rr6s
Recruiting
Phase 3

PREVER Study: Efficacy of the combination of Chlorthalidone and Amiloride versus placebo in the prevention of hypertension in patients with prehypertension PREVER 1 Study - PREVER 1 Study: Prevention of Cardiovascular outcomes in patients with prehypertension

Hospital de Clínicas de Porto Alegre0 sitesMarch 2, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrehypertension

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Prehypertension
Sponsor
Hospital de Clínicas de Porto Alegre
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 2, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Hospital de Clínicas de Porto Alegre

Eligibility Criteria

Inclusion Criteria

  • •I. individuals with 30 to 70 years of age
  • •II. Systolic Arterial Pressure 120\-139 mmHg or Diastolic Arterial Pressure 80\-89 mmHg;

Exclusion Criteria

  • •I. Previous diagnosis of hypertension or use of antihypertensive drugs;
  • •II. Allergies to Chlorthalidone Amiloride;
  • •III. Known cardiovascular disease (previous Miocardial Infarction, previous stroke, heart failure or clinical manifestations, for example, current or previous angina, intermittent claudication ...);
  • •IV. Chronic diseases that limit the participation or the prospect of life (such as cancer, rheumatic disease, disability, etc.);
  • •V. Analgesics or anti\-inflammatory use for 30 days or more;
  • •VI. Inability to measure blood pressure;
  • •VII. Difficulty in understanding that limits participation in the study;
  • •VIII. IF WOMEN: Pregnant or planning to become pregnant in the next two years;
  • •IX. Patients who have participated in other randomized trials (the last six months);

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A study of the efficacy of a combination of chlorambucil and lomustine and etoposide (CLE 56) for absolute refractory prostate cancerProstate cancerCancer
ISRCTN50615178Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)40
Not yet recruiting
Phase 3
Evaluation Between Chlorhexidine Gel And Herbal Gel for Periodontal Treatment
CTRI/2024/05/067879Datta Meghe Institute of Higher Education and Research
Not yet recruiting
Phase 2
Efficacy and safety of Chlorpromazine in the treatment of COVID-19 patients
IRCT20200913048708N1Mazandaran University of Medical Sciences60
Completed
Phase 1
use of different treatment techniques on same patient to reduce gum infection of patient undergoing orthodontic treatment
CTRI/2018/02/012191Sreedevi K20
Completed
Not Applicable
chloral hydrate, combination of chloral hydrate - promethazine and combination of chloral hydrate - hydroxyzine in sedation induction for electroencephalography of childreepilepsy.Epilepsy and paroxysmal disordersG40, G47
IRCT201204262639N8Ali-ebn-Abitaleb School of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran90